Product Theaters
- Events
- Product Theaters
VASCEPA® (icosapent ethyl)—Elevating the Standard of Care
A Collaborative Discussion to Better Understand and Expedite the Patient Journey
Developed and offered by someone
Another line
We won't add links - this is only a test
H2
- HTML possible
- in excerpt
Enabling Telemedicine and Remote Monitoring With the Freestyle Libre 14 Day System (This Product Theater is Pre-Recorded)
Join us to learn about the #1 CGM worldwide† used by more than 2 million people*, the FreeStyleLibre 14-day system.Daniel Einhorn, MD, FACP, FACE, will share how he utilizes the […]
Thinking Beyond Glycemia—The Importance of Managing Heart Failure Risks in Type 2 Diabetes (This Product Theater is Pre-Recorded)
We will examine the risk of heart failure (HF) among patients with type 2 diabetes (T2D) and explore evidence-based risk reduction strategies that you can incorporate into your practice. We will discuss the results of the DECLARE trial, the largest cardiovascular (CV) outcomes trial to study hospitalization for HF risk reduction in patients with T2D […]
Are We Waiting Too Long to Start a GLP-1RA in Adult Patients with T2D? (For Non-U.S. HCPs Only) (This Product Theater is Pre-Recorded)
This presentation provides an overview of a GLP-1RA for adult patients with T2D, including an in-depth review of head-to-head data from the clinical trial program. The results from a CVOT will also be reviewed. Presenter: Adie Viljoen, MB, ChB, FCP, MD, FRCPath, MBAConsultant Metabolic PhysicianThe Lister HospitalStevenage, United Kingdom
VASCEPA® (icosapent ethyl)—Elevating the Standard of Care (This Product Theater is Presented Live)
There is an urgency to treat Persistent Cardiovascular Risk (P-CVR) as it remains high despite statin-based standard-of-care therapy in patients with elevated triglycerides. In this program, we will review data from a practice changing trial that provides a new therapeutic option to elevate the current standard of care.Presenter: Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE […]
Considerations for Glycemic Control—Choosing a Basal Insulin for Patients with Diabetes (This Product Theater is Pre-Recorded)
Presenter: Helen Baron, MD, CCDMedical Director, Diabetes ServicesEisenhower Diabetes and EndocrinologyEisenhower Medical AssociatesRancho Mirage, CA
Renal and Cardiovascular Outcomes in Adults with Diabetic Nephropathy (i.e., DKD) and Type 2 Diabetes (U.S. Only) (This Product Theater is Presented Live. It Will Not Be Available On Demand)
Topics include:•Renal and cardiovascular outcomes and overall safety profile in adults with diabetic nephropathy(i.e., diabetic kidney disease) and type 2 diabetes•Important Safety Information, followed by a question-and-answer sessionPresenter: Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACEEndocrinologistMedical Director & Principal InvestigatorMetabolic Institute of AmericaTarzana, CA
Understanding Chronic Kidney Disease in Type 2 Diabetes—The Risks, Recognition, and Clinical Management (This Product Theater is Presented Live. It Will Not Be Available On Demand)
Chronic Kidney Disease (CKD) develops in a substantial proportion of patients with type 2 diabetes (T2D) and significantly increases risk for adverse cardiovascular and renal outcomes. Multiple factors can contribute to the development and progression of CKD in T2D, although understanding of the etiology continues to evolve. The deleterious impact of CKD in T2D progresses […]
Break the Sequential T2DM Treatment Pattern in Adult Patients with High A1C (≥9%) on OADs, or Uncontrolled on GLP-1 Ras, and get them to Goal (This Product Theater is Pre-Recorded)
Presenter: Jeremy Pettus, MDAssistant Professor of MedicineDivision of EndocrinologyUniversity of California, San DiegoSan Diego, CA
Simplifying Diabetes Management—Advancing Innovation Across Outcomes, Patient Experience, and Support with the Guardian™ Connect Continuous Glucose Monitoring (CGM) System (U.S. Only) (This Product Theater is Pre-Recorded)
Please join us for a virtual product theater on Medtronic’s cutting-edge Guardian™ Connect continuous glucose monitoring (CGM) technology and the role it plays in virtual diabetes care. You will hear from Dr. Amit Bhargava, MD about real-world outcomes and case studies of patients using the Guardian™ Connect system with the Sugar.IQ™ diabetes assistant. This will […]